Featured Research

from universities, journals, and other organizations

Global rise in type 1 diabetes may be linked to reduced exposure to pathogens in early life

Date:
March 19, 2013
Source:
Society for Endocrinology
Summary:
Countries with lower mortality from infectious disease exhibit higher rates of type 1 diabetes, according to a new study. The findings suggest that the as yet unexplained global rise in type 1 diabetes may be linked to reduced exposure to pathogens in early life.

Countries with lower mortality from infectious disease exhibit higher rates of type 1 diabetes, according to a new study by Dr. A. Abela and Professor S. Fava of the University of Malta. The findings, collating data from three major international studies and presented at the Society for Endocrinology annual conference in Harrogate UK, suggest that the as yet unexplained global rise in type 1 diabetes may be linked to reduced exposure to pathogens in early life.

Type 1 diabetes is caused when the immune system destroys the cells of the pancreas that release insulin, leaving the patient unable to control his own blood sugar. It is estimated to affect around half a million children worldwide, increasing in incidence by an estimated 3% every year. This increase is well documented and is linked to the developed world, but is so far unexplained -- various theories put forward include the 'hygiene hypothesis', which suggests that encounters between the developing immune system and micro-organisms such as bacteria and parasites are part of human evolution and may therefore protect against the development of auto-immunity.

The researchers investigated whether markers of infectious disease burden could be linked to the local incidence of type 1 diabetes. They used data from the World Health Organisation (WHO) DiaMond Project, WHO global burden of disease: 2004 update, and the Alexander Project, to correlate type 1 diabetes incidence by country with mortality from infectious disease and bacterial antibiotic susceptibility (which indicates antibiotic use and thus exposure to bacterial infection).

Type 1 diabetes rates were highest in countries with low mortality from infectious disease. This was true for total mortality from infectious disease (r=-0.35, p=0.008), as well as deaths caused specifically by diarrhea, respiratory disease, tuberculosis, and infections and parasitic disease (all p<0.05). They also found type 1 diabetes rates are significantly associated with the local susceptibility of the bacteria Streptococcus pneumoniae to all antibiotics studied.

This study suggests that there may be an association between type 1 diabetes rates and infectious disease burden. It is possible that the increasing global incidence of type 1 diabetes may be linked to lack of exposure to pathogens during early life. Whilst the data provide support for the hygiene hypothesis they do not prove it: the rise in type 1 diabetes rates is a complex problem and this study is of association only. Other potential contributing factors may show a similar geographical variation to infectious disease burden, as this is linked to the developed world. The authors are keen to use further studies to identify other environmental factors which may predispose to type 1 diabetes.

Study leader Professor Stephen Fava, Consultant in Diabetes and Endocrinology at Mater Dei Hospital, Malta & Associate Professor of Medicine at the University of Malta, said:

"The global rise in type 1 diabetes is an unexplained phenomenon. Many suggest that the exposure, or rather the lack of exposure, to infectious disease when young might be linked to the development of autoimmunity.

"Our data show that type 1 diabetes rates were highest in countries where markers of exposure to infectious disease were lowest. Incidence of type 1 diabetes was significantly linked to mortality from a variety of infectious diseases and to the local susceptibility of a common bacterium to antibiotics.

"These data provide support for the notion that the immune system can somehow become disordered and attack the body's own cells if it is not trained by regular exposure to micro-organisms -- the so called hygiene hypothesis. More research is needed to try to identify other environmental factors that may be linked to the continuing conundrum of rising type 1 diabetes rates."


Story Source:

The above story is based on materials provided by Society for Endocrinology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Alexia-Giovanna Abela, Stephen Fava. Association of the incidence of type 1 diabetes with markers of infection and antibiotic susceptibility at country level. Endocrine Abstracts, 2013; 1 DOI: 10.1530/endoabs.31.P223

Cite This Page:

Society for Endocrinology. "Global rise in type 1 diabetes may be linked to reduced exposure to pathogens in early life." ScienceDaily. ScienceDaily, 19 March 2013. <www.sciencedaily.com/releases/2013/03/130318203334.htm>.
Society for Endocrinology. (2013, March 19). Global rise in type 1 diabetes may be linked to reduced exposure to pathogens in early life. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2013/03/130318203334.htm
Society for Endocrinology. "Global rise in type 1 diabetes may be linked to reduced exposure to pathogens in early life." ScienceDaily. www.sciencedaily.com/releases/2013/03/130318203334.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins